|
|
|
|
| Paper Summary: Topics Discussed include: Oncolytic viruses for cancer therapy, Multiple Myeloma is an appealing target for intravenous virotherapy, Attenuated measles for myeloma, High CD46 expression in primary myeloma cells, NIS gene insertion for imaging virus spread (MV-NIS), Intravenous MV-NIS: Dose-response studies, Malignant plasma cells are preferentially infected by MV-GFP, and potent antimyeloma oncolytic, fatal toxicity. |
| Click here to view Text Version | To view full screen click here!
|
|
 Loading.... |
| If you are unable to view this PDF file, please clear your browser cache and reload your page,if the problem persists try upgrading your PDF reader. To obtain the PDF reader, please click here
|
| |
This paper was posted by
 |
WeSRCH - Selected for Net Excellence
|
|
|
|
|
|
| Short URL: http://medical.wesrch.com/pdfME1LYY000TRNW |
|
|
|
|
|
|
|
|
|
|
